Trial
NCT01674829
A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
CHABiotech CO., Ltd
Collaborators
—
Condition
Dry Age Related Macular Degeneration
Intervention
MA09-hRPE
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-09